BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 7642585)

  • 1. Truncated forms of the human prion protein in normal brain and in prion diseases.
    Chen SG; Teplow DB; Parchi P; Teller JK; Gambetti P; Autilio-Gambetti L
    J Biol Chem; 1995 Aug; 270(32):19173-80. PubMed ID: 7642585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues.
    Jiménez-Huete A; Lievens PM; Vidal R; Piccardo P; Ghetti B; Tagliavini F; Frangione B; Prelli F
    Am J Pathol; 1998 Nov; 153(5):1561-72. PubMed ID: 9811348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein.
    Petersen RB; Parchi P; Richardson SL; Urig CB; Gambetti P
    J Biol Chem; 1996 May; 271(21):12661-8. PubMed ID: 8647879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation.
    Singh N; Zanusso G; Chen SG; Fujioka H; Richardson S; Gambetti P; Petersen RB
    J Biol Chem; 1997 Nov; 272(45):28461-70. PubMed ID: 9353306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities in stress proteins in prion diseases.
    Tatzelt J; Voellmy R; Welch WJ
    Cell Mol Neurobiol; 1998 Dec; 18(6):721-9. PubMed ID: 9876878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein transgenes and the neuropathology in prion diseases.
    DeArmond SJ; Prusiner SB
    Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and genetics of prion diseases.
    Prusiner SB
    Annu Rev Microbiol; 1994; 48():655-86. PubMed ID: 7826022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A trend of molecular genetics on prion diseases and prion protein].
    Muramatsu Y; Shinagawa M
    Nihon Rinsho; 1993 Sep; 51(9):2494-502. PubMed ID: 8411733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
    Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
    Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of transmissible spongiform encephalopathies.
    Weber T; Aguzzi A
    Intervirology; 1997; 40(2-3):198-212. PubMed ID: 9450236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prions mediated neurodegenerative disorders.
    Huang WJ; Chen WW; Zhang X
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4028-34. PubMed ID: 26592824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant prion protein-mediated aggregation of normal prion protein in the endoplasmic reticulum: implications for prion propagation and neurotoxicity.
    Gu Y; Verghese S; Mishra RS; Xu X; Shi Y; Singh N
    J Neurochem; 2003 Jan; 84(1):10-22. PubMed ID: 12485397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoproteolytic processing of the mammalian prion glycoprotein family.
    Mays CE; Coomaraswamy J; Watts JC; Yang J; Ko KW; Strome B; Mercer RC; Wohlgemuth SL; Schmitt-Ulms G; Westaway D
    FEBS J; 2014 Feb; 281(3):862-76. PubMed ID: 24286250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
    Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
    OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transmission of spongiform encephalopathies (prion diseases)].
    Federspil P; Federspil PA
    HNO; 2002 Apr; 50(4):316-26. PubMed ID: 12063689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating recombinant C-terminal prion protein fragments of exact native sequence.
    Johanssen VA; Barnham KJ; Masters CL; Hill AF; Collins SJ
    Neurochem Int; 2012 Feb; 60(3):318-26. PubMed ID: 22197912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of PrP in health and disease.
    Flechsig E; Weissmann C
    Curr Mol Med; 2004 Jun; 4(4):337-53. PubMed ID: 15354865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.